Recently an enhancer region located ~1 kb past the shared 3′UTR has been identified and shown to bind the myeloid-specific transcription factor GATA-2 [22], with abundant expression of GATA-2 and WT1 in AML being associated with bad prognosis [23]. Here, WT1 is linked to acute myeloid leukemia.